ConductScience.org, home

Paper23744281

The benefits and harms of breast cancer screening: an independent review.

Marmot MG and 5 others. Br J Cancer, 2013. Cited by 751 papers, by iCite.

Cite this record

ConductScience Library. The benefits and harms of breast cancer screening: an independent review. Papers, record 23744281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23744281

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The benefits and harms of breast cancer screening: an independent review.
PubMed
Journal
Br J Cancer
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
751
iCite
Relative citation ratio, by iCite
25.1
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marmot MGM G
2Altman DGD G
3Cameron DAD A
4Dewar JAJ A
5Thompson SGS G
6Wilcox MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Aged
Diagnostic Errors
Early Detection of Cancer
Evidence-Based Medicine
Female
Humans
Middle Aged
Randomized Controlled Trials as Topic
Risk Assessment
United Kingdom

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G19/35Medical Research CouncilUnited KingdomPubMed
G0100222Medical Research CouncilUnited KingdomPubMed
RG/08/014/24067British Heart FoundationUnited KingdomPubMed
MR/L003120/1Medical Research CouncilUnited KingdomPubMed
MC_U105260792Medical Research CouncilUnited KingdomPubMed
RG/07/008/23674British Heart FoundationUnited KingdomPubMed
G8802774Medical Research CouncilUnited KingdomPubMed
G0902037Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in23744279Mortality benefits and overdiagnosis estimates for women attending breast screening.https://conductscience.org/library/papers/23744279PubMed
Comment in23744280Breast cancer screening: time to target women at risk.https://conductscience.org/library/papers/23744280PubMed

Download CSV of comments and corrections

References250

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115957172Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden.Int J Cancer2005https://conductscience.org/library/papers/15957172PubMed
21886969Suicide attitude in breast cancer patients.Psychopathology1991https://conductscience.org/library/papers/1886969PubMed
321425135Prognosis and pathology of screen-detected carcinomas: how different are they?Cancer2011https://conductscience.org/library/papers/21425135PubMed
421658405Overdiagnosis in breast cancer: design and methods of estimation in observational studies.Prev Med2011https://conductscience.org/library/papers/21658405PubMed
515601639Biennial versus annual mammography and the risk of late-stage breast cancer.J Natl Cancer Inst2004https://conductscience.org/library/papers/15601639PubMed
615958448Evaluation of service screening mammography in practice: the impact on breast cancer mortality.Ann Oncol2005https://conductscience.org/library/papers/15958448PubMed
721892702Impact of mammographic screening on the detection of good and poor prognosis breast cancers.Breast Cancer Res Treat2011https://conductscience.org/library/papers/21892702PubMed
82702641Presence of a growth-stimulating factor in serum following primary tumor removal in mice.Cancer Res1989https://conductscience.org/library/papers/2702641PubMed
922273850Mammography screening: time to reevaluate its impact?Eur J Cancer Prev2012https://conductscience.org/library/papers/22273850PubMed
1020840283Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?Ann N Y Acad Sci2010https://conductscience.org/library/papers/20840283PubMed
1122028484The NHS breast screening programme needs independent review.BMJ2011https://conductscience.org/library/papers/22028484PubMed
1222972811False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.J Med Screen2012https://conductscience.org/library/papers/22972811PubMed
1311336243Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy.Breast Cancer Res Treat2001https://conductscience.org/library/papers/11336243PubMed
1422282190The Two-County breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening.Radiology2012https://conductscience.org/library/papers/22282190PubMed
1515649904Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.BMJ2005https://conductscience.org/library/papers/15649904PubMed
1622612610Hormone therapy and breast cancer risk 10 years after the WHI.Climacteric2012https://conductscience.org/library/papers/22612610PubMed
1715770005Risk of cardiac death after adjuvant radiotherapy for breast cancer.J Natl Cancer Inst2005https://conductscience.org/library/papers/15770005PubMed
1821996169Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.Lancet Oncol2011https://conductscience.org/library/papers/21996169PubMed
1917665313Protection of mammography screening against death from breast cancer in women aged 40-64 years.Cancer Causes Control2007https://conductscience.org/library/papers/17665313PubMed
2017442911The decrease in breast-cancer incidence in 2003 in the United States.N Engl J Med2007https://conductscience.org/library/papers/17442911PubMed

See all 250 referencesDownload CSV of references

Cited by466

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 751 citations.

PMIDTitleJournalYearIn PapersSource
42960158Cost-effectiveness of digital breast tomosynthesis versus digital mammography for breast cancer screening: a systematic literature review.Asian Biomed (Res Rev News)2026https://conductscience.org/library/papers/42960158PubMed
42934774Explainable vision transformer framework for breast lesion classification with Grad-CAM support.Cancer Imaging2026https://conductscience.org/library/papers/42934774PubMed
42867728Optimizing AI-assisted decision-making in mammography screening: focusing on uncertainties.Insights Imaging2026https://conductscience.org/library/papers/42867728PubMed
42701602Implementation of an artificial intelligence-based system for mammography in the compulsory medical insurance program: results of a 3-year study.Quant Imaging Med Surg2026https://conductscience.org/library/papers/42701602PubMed
42688776Increasing participation of underrepresented groups in cancer early detection research: a scoping review.Front Public Health2026https://conductscience.org/library/papers/42688776PubMed
42645960MB-SwinRefiner: Mammographic Mass Segmentation with Probability-Guided Residual Refinement.J Imaging2026https://conductscience.org/library/papers/42645960PubMed
42642748It depends on where you stand on screening: health professionals' awareness, perspectives, and approaches to overdiagnosis in cancer screening - a qualitative interview study.BMC Health Serv Res2026https://conductscience.org/library/papers/42642748PubMed
42615544Estimating lead time and overdiagnosis in cancer screening programmes: the MOCCI method.Int J Epidemiol2026https://conductscience.org/library/papers/42615544PubMed
42547590Artificial intelligence in breast cancer imaging: a systematic review of diagnostic performance, predictive modeling, and clinical translation.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42547590PubMed
42512215Uncertainty Quantification in Zip Code Tabulation Area-Level Breast Cancer Screening: A Bayesian Geospatial Analysis in Hillsborough County, Florida.Int J Environ Res Public Health2026https://conductscience.org/library/papers/42512215PubMed
42469440Risk-based breast cancer screening.Br J Cancer2026https://conductscience.org/library/papers/42469440PubMed
42418475A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.PLoS One2026https://conductscience.org/library/papers/42418475PubMed
42362870Long-term effectiveness and overdiagnosis in the NHS breast screening programme: a cohort study with up to 33 years of follow-up.Br J Cancer2026https://conductscience.org/library/papers/42362870PubMed
42356884
Cross-Sensor and Cross-Population Generalization of Deep Learning Models for Digital Mammography: A Controlled Four-Country Benchmark of Five Backbone Architectures with Statistical Significance Testing.
Sensors (Basel)2026https://conductscience.org/library/papers/42356884PubMed
42332007Association between risk-related lifestyle factors, screening adherence and breast cancer incidence: a decomposition analysis.Sci Rep2026https://conductscience.org/library/papers/42332007PubMed
42313161Location of AI risk markers and associated mammographic features in screening mammograms obtained years before screen-detected breast cancer.Eur Radiol2026https://conductscience.org/library/papers/42313161PubMed
42091662High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases.Eur Radiol2026https://conductscience.org/library/papers/42091662PubMed
42014777Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada.Commun Med (Lond)2026https://conductscience.org/library/papers/42014777PubMed
41975698Performance of a Screening Mammography AI Algorithm Repurposed for Symptomatic Mammography in a Tertiary Outpatient Clinic.Diagnostics (Basel)2026https://conductscience.org/library/papers/41975698PubMed
41946926A foundation generative model for breast ultrasound image analysis.Nat Biomed Eng2026https://conductscience.org/library/papers/41946926PubMed

See all 466 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
SPINK511005PubTator's text mininghttps://conductscience.org/library/genes/11005NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23744281

GET https://conductscience.org/api/papers/v1/23744281/references?page=2